Furthermore, these findings may be applicable to a wider variety of cancers, as neurofibromin loss is found in breast cancer; gastrointestinal stromal tumors; neuroblastomas; rhabdomyosarcoma; and juvenile myelomonocytic leukemia; and others [32]. Here, NF1 is linked to cancer.